Complementing chronic frailty assessment at hospital admission with an electronic frailty index (FI-Laboratory) comprising routine blood test results

Hugh Logan Ellis, Bettina Wan, Michael Yeung, Arshad Rather, Imran Mannan, Catherine Bond, Catherine Harvey, Nadia Raja, Peter Dutey-Magni, Kenneth Rockwood, Daniel Davis, Samuel D. Searle

Résultat de recherche: Articleexamen par les pairs

55 Citations (Scopus)

Résumé

BACKGROUND: Acutely ill and frail older adults have complex social and health care needs. It is important to understand how this complexity affects acute outcomes for admission to hospital. We validated a frailty index using routine admission laboratory tests with outcomes after patients were admitted to hospital. METHODS: In a prospective cohort of older adults admitted to a large tertiary hospital in the United Kingdom, we created a frailty index from routine admission laboratory investigations (FI-Laboratory) linked to data comprising hospital outcomes. We evaluated the association between the FI-Laboratory and total days spent in hospital, discharge to a higher level of care, readmission and mortality. RESULTS: Of 2552 admissions among 1750 older adults, we were able to generate FI-Laboratory values for 2254 admissions (88.3% of the cohort). More than half of admitted patients were women (55.3%) and the mean age was 84.6 (SD 14.0) years. We found that the FI-Laboratory correlated weakly with the Clinical Frailty Scale (CFS; r2 = 0.09). An increase in the CFS and the equivalent of 3 additional abnormal laboratory test results in the FI-Laboratory, respectively, were associated with an increased proportion of inpatient days (rate ratios [RRs] 1.43, 95% confidence interval [CI] 1.35-1.52; and 1.47, 95% CI 1.41-1.54), discharge to a higher level of care (odd ratios [ORs] 1.39, 95% CI 1.27-1.52; and 1.30, 95% CI 1.16-1.47) and increased readmission rate (hazard ratios [HRs] 1.26, 95% CI 1.17-1.37; and 1.18, 95% CI 1.11-1.26). Increases in the CFS and FI-Laboratory were associated with increased mortality HRs of 1.39 (95% CI 1.28-1.51) and 1.45 (95% CI 1.37-1.54), respectively.

Langue d'origineEnglish
Pages (de-à)E3-E8
JournalCMAJ
Volume192
Numéro de publication1
DOI
Statut de publicationPublished - janv. 6 2020

Note bibliographique

Funding Information:
Funding: Hugh Logan Ellis is supported by a UCLH CEO Clinical Research Fellowship. Kenneth Rockwood receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research, and research support through grants from the Canadian Frailty Network, the Nova Scotia Health Research Foundation, the Nova Scotia Health Authority Research Fund and the Fountain Family Innovation Fund of the QEII Health Sciences Centre Foundation. He is Associate Director of the Canadian Con- sortium on Neurodegeneration in Aging, which is funded by the Canadian Institutes of Health Research (CAN-137794). Daniel Davis is funded through a Wellcome Intermediate Clinical Fellowship (WT107467). Samuel Searle is supported with fellowship funding from the Dal-housie Medical Research Foundation, the Queen Elizabeth II Health Sciences Centre Foundation, as a Detweiler Travelling Fellow, and through the Canadian Frailty Network with an Interprofessional fellowship. The funders played no role in the writing of the manuscript.

Funding Information:
Hugh Logan Ellis is supported by a UCLH CEO Clinical Research Fellowship. Kenneth Rockwood receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research, and research support through grants from the Canadian Frailty Network, the Nova Scotia Health Research Foundation, the Nova Scotia Health Authority Research Fund and the Fountain Family Innovation Fund of the QEII Health Sciences Centre Foundation. He is Associate Director of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian Institutes of Health Research (CAN-137794). Daniel Davis is funded through a Wellcome Intermediate Clinical Fellowship (WT107467). Samuel Searle is supported with fellowship funding from the Dalhousie Medical Research Foundation, the Queen Elizabeth II Health Sciences Centre Foundation, as a Detweiler Travelling Fellow, and through the Canadian Frailty Network with an Interprofessional fellowship. The funders played no role in the writing of the manuscript.

Publisher Copyright:
© 2020 Joule Inc. or its licensors

ASJC Scopus Subject Areas

  • General Medicine

Empreinte numérique

Plonger dans les sujets de recherche 'Complementing chronic frailty assessment at hospital admission with an electronic frailty index (FI-Laboratory) comprising routine blood test results'. Ensemble, ils forment une empreinte numérique unique.

Citer